Expertise: Laboratory automation, compound management, high throughput screening, drug discovery, assay development, screening technologies, liquid handling, microfluidics, biobanking, biorepository automation, biostorage and environmental repository operation, business development, process analysis and recommendation, system integration and implementation, project management.
Director Parkinsonâ€™s Disease Group Neurodegeneration DPU, GlaxoSmithKline.
Expertise: Target and lead identification and validation, biomarkers discovery, biobanking, phenotypic screening
David John Hayes
Expertise: Drug discovery, assay development, enzymology, HTS, biomarker discovery, immuno-assay, multiplex technologies, label-free technologies, protein biochemistry, toxicity, cell based assays, kinases, proteases
Team Leader Innovative Medicines and Early Development Discovery Sciences - Cellular Assay Development Astrazeneca
Expertise: Target and lead identification and validation, biomarkers discovery, cell based assay, assay development and validation
Neurosciences Centre of Excellence for Drug Discovery
Expertise: target and lead identification and validation, biomarkers discovery, ADME, pharmacology, in vivo pharmacology, preclinical experimental design, lean drug discovery and development, compoound selection and optimization
University of Wales
Expertise: Assay development, laboratory automation, high content imaging, mass spectrometry, LIMS.
Juan Manuel Dominguez
Expertise: enzymology, protein biochemistry, assay development and validation, mode of action studies.
Krishna P Kota
United States Army Medical Institute of Infectious Diseases
Expertise: Cell based assay, High Content Screening, High Throughput Screening, Proteomics
Leonardo J. Solmesky
Weizmann Institute of Science
Expertise: Laboratory automation, assay development and validation, high content analysis, biomarkers discovery, cell based assay, phenotypic screening, facility management, and personalized drug discovery
Luigi Piero Stasi
Expertise: Medicinal chemistry, lead identification, ADME, CNS.
Unisannio Univ, Benevento
Expertise: Cell Based Assay, Cell Culture, Miscroscopy, Flow Cytometry, Cell Biology, Pharmacology, Toxicology, Molecular Biology, Protein Biochemistry, Protein-Protein Interaction, Epigenetic and Neurodegenerative Diseases
Automation & Research Technologies Team Chair, AstraZeneca
Expertise: Compound Management, high throughput screening, biobanking, assay development, laboratory automation development and implementation, laboratory information systems, value chain optimization and operations, change management leadership, cross-functional team building, process improvement
Ming Qiang Zhang
Vice President & Head Research & Development China, Amgen Inc.
Expertise: Medicinal chemistry of antiviral, anticancer, anti-inflammatory/anti-allergic, CNS, agents, Heterocyclic, neucleside/tides, carbohydrate, national products / macrocycles, supramolecular / host-guest chemistry, Biomarker, patient stratification, clinical trials and regulatory
Stem Cell Solutions Ltd
Expertise: Screening technologies, target identification and validation, laboratory automation, assay development and validation, high content analysis, data mining, biomarkers discovery, biobanking, cell based assays, use of stem cells in drug discovery, iPS-disease modelling, phenotypic screening
Associate Director Biology, GVK Biosciences
Expertise: Drug metabolism and pharmacokinetics, pharmacogenomics, pharmacology, toxicology, molecular biology.
Expertise: Computational chemistry, cheminformatics, structure-based drug discovery, ligand-based drug design, bioinformatics, virtual Screening, hit-to-lead, medicinal chemistry, antibody modeling, protein design.
Founder and CEO, iDDPartners
Expertise: Target identification-validation, high throughput screening, pharmacology, PK/PD, ADME.
Neuroscience Therapeutic Area Unit, GlaxoSmithKline
Expertise: Screening technologies, target and lead identification and validation, laboratory automation, assay development and validation, biomarkers discovery, ADME, BioMEMS, Phenotypic screening.
Expertise: Target identification and validation, assay development and validation, high content analysis and screening, biomarkers discovery, biobanking, cell based assay, cell culture, miscroscopy, flow cytometry, stem cells.
Senior Research Scientist, Orchid Chemicals & Pharmaceuticals Ltd
Expertise: Target and lead identification and validation, in vitro and in vivo pharmacology, disease models, biomarker discovery.
University of California
Expertise: Assay development, high throughput screening, enzymology, biochemical assays, cell-based assays, drug discovery, high content analysis, data mining, biomarkers discovery, ADME, microfluidics, sample management, cell based assay, 3D cell culture.
Sr. Scientific Manager, Genentech Inc
Expertise: Screening technologies, laboratory automation, high throughput screening, assay development and validation, data mining, microfluidics, sample management, cell based assays and biobanking.
BIT Pharma GmbH
Expertise: Non-clinical and early clinical pharmacology in the areas of inflammatory and autoimmune diseases, diabetes type 1 and type 2, obesity, neurodegeneration, neuropsychopharmacology, oncology, respiratory diseases and in vivo phenotyping screening. In vitro pharmacology, assay development and validation, bioanalytics, biomarker discovery and translational medicine.
General Manager of Discovery Screening, Mitsubishi Tanabe Pharma Corporation
Expertise: small molecule drug discovery, high throughput screening, screening technologies, lead identification and validation, laboratory automation, ADMET-HTS, sample management and natural products screening
Expertise: Pharmacology, Toxicology, Pharmacokinetics, Medical Plants, Antineoplastic drugs